⌘K

13:03:05·1298d

13D/GFilingvia Quantisnow

SEC Form SC 13G filed by Ginkgo Bioworks Holdings Inc.

ByQuantisnow·Wall Street's wire, on your screen.

DNA· Ginkgo Bioworks Holdings Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

DNA
Ginkgo Bioworks Holdings Inc.
Health Care

Recent analyst ratings

May 15UpdateBTIG Research-
May 10UpdateWilliam Blair-
Nov 14UpdateRaymond James$2.50
Nov 9UpdateBTIG Research-
Jun 2UpdateGoldman$1.25
May 11UpdateWilliam Blair-

Related

PR1d
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation
SEC2d
SEC Form DEFA14A filed by Ginkgo Bioworks Holdings Inc.
SEC2d
SEC Form DEF 14A filed by Ginkgo Bioworks Holdings Inc.
INSIDER11d
SEC Form 4 filed by Coen Steven P.
INSIDER17d
SEC Form 4 filed by Coen Steven P.
INSIDER18d
SEC Form 4 filed by Canton Barry
INSIDER18d
SEC Form 4 filed by Shetty Reshma P.
INSIDER21d
SEC Form 4 filed by Shetty Reshma P.